New Hepatitis C drug helps Romanian pharma market grow 16.3% y/y in Q2

Romania's pharmaceuticals market expanded by 16.3% on the year to 3.29 billion lei ($830 million/739 million euro) for the second quarter of 2016, mostly due to a subsidized sales of a new Hepatitis C drug, a survey by market researcher Cegedim Romania showed on Monda, seenews.com informs. "Market growth in the second quarter of 2016 was due to two reasons: firstly, the market value for the second quarter of 2015 was unusually small, due to lower ...

Developed by Codecraftsman